Neurotoxicity of artemisinin: Possible counseling and treatment of side effects

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1330-1331

  Elias, Ziyad ^a   Bonnet, Eric ^a   Marchou, Bruno ^a   Massip, Patrice ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MALARIA FALCIPARUM; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREMOR;

EID: 0033053412     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517789     Document Type: Article

References (5)

1. 1. Brewer TG, Grate SJ, Peggins JO, et al. Fatal neurotoxicity of arteemeter and artemether. Am J Trop Med Hyg 1994;51:251-9.
2. 2. Petras JM, Kyle DE, Gettayacamin M, et al. Arteether: risks of two week administration in Macaca mulatta. Am J Trop Med Hyg 1997:56: 390-6.
3. 3. Senanayake N, de Silva HJ. Delayed cerebellar ataxia complicating Falciparum malaria: a clinical study of 74 patients. J Neurol 1994;241:456-9.
4. 4. Davis TM, Breheny FX, Kendall PA, et al. Severe Falciparum malaria with hyperparasitemia treated with intravenous artesunate. Med J Aust 1997; 166:416-8.
5. 5. Britton TC. Essential tremor and it's variants. Curr Opin Neurol 1995;4: 314-9.